Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

ACT-078573 shows improvement in sleep efficiency in primary insomnia

Feb. 8, 2007

Transtec shown to be safe and effective for treatment of cancer pain

Feb. 8, 2007

Avicena completes dose-escalating portion of chronic toxicology study of PD- 02

Feb. 8, 2007

elbion and Wyeth team up on PDE10 inhibitors for CNS disorders

Feb. 8, 2007

Treatment completed in phase III trials of Miraxion in Huntington's disease

Feb. 7, 2007

Novel activation mechanism for the pain-sensing TRPA1 channel / News in Context

Feb. 7, 2007

NF-kappaB inhibitors inhibit Abeta production in vitro: potential efficacy in AD

Feb. 7, 2007

Blockade of the orexin OX1/OX2 receptors with ACT-078573 promotes sleep in rats, dogs and humans

Feb. 6, 2007

Shionogi and Lilly to codevelop and comarket duloxetine in Japan

Feb. 6, 2007

Neurochem completes North American phase III study of tramiprosate

Feb. 6, 2007

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...